Market News AIOpen the app

MTNB stock news · Matinas BioPharma Holdings

Stories about Matinas BioPharma Holdings (MTNB) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for MTNB

Follow Matinas BioPharma Holdings (MTNB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MTNB
Free on the App Store and Google Play, or on the web.
  1. Oct 30, 2026, 5:23 PM ET · Market

    On Friday evening, 12 health care stocks changed a lot in price, with Inovio up 292.6% and Precigen down 26.5%.

    Neutral

    Matinas BioPharma shares fell 22% in Friday's after-hours session. The article gives no company update or reason for the fall, so it does not change the business outlook.

  2. Oct 19, 2026, 1:17 PM ET · Market

    12 health care companies are seeing big changes in their stock prices today.

    Neutral

    The article reports a fall in Matinas BioPharma shares but gives no company news explaining it. The share move alone does not change what the article says about the company.

  3. Oct 19, 2026, 8:14 AM ET · Market

    12 health care stocks are changing a lot before the market opens on Monday.

    Neutral

    Matinas BioPharma shares fell about 9% before trading began. The story gives no reason or company news, so it does not change the company's business outlook.

  4. Oct 5, 2026, 5:16 PM ET · Market

    Here are 12 health care stocks that changed in value after the market closed on Monday.

    Neutral

    Matinas BioPharma Hldgs shares fell in after-hours trading. The report gives no business reason for the move, so it does not change the company's outlook.

  5. Sep 28, 2026, 8:42 AM ET · Market

    Matinas BioPharma Holdings, Inc. is changing the rules for its shareholders with a one-for-fifteen stock split.

    Neutral

    Matinas BioPharma completed a 1-for-15 share split. It changed share counts, not owners’ percentage stakes or authorized shares, so it does not change the company’s outlook.

  6. Sep 16, 2026, 5:52 PM ET · Market

    Matinas BioPharma will combine its shares, making every fifteen shares into one starting September 28, 2026.

    Neutral

    Matinas approved a 1-for-15 reverse split effective Sep 28, 2026; it aims to support NYSE American listing, but success is not guaranteed, so the change is neutral.